Esophageal Neoplasms: all 1,631 studies
Page 9 of 17. Open to participants first (469), then studies with results posted, then the rest; newest registration first within each.
- Thromboprophylaxis in Oesophageal Cancer PatientsStatus unknownNCT05067153Phase 4
- A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid TumoursActive, not recruitingNCT05057013Phase 1/2
- Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's EsophagusStatus unknownNCT05056051Not applicable
- Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic FunctionWithdrawnNCT05048368Phase 1
- Wet Heparinized Suction for Abdominal CancerWithdrawnNCT05041335Not applicable
- Study of Epigallocatechin-3-gallate (EGCG) for Supportive and Symptomatic Management in Patients With Esophageal CancerCompletedNCT05039983Phase 1
- Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse EventsActive, not recruitingNCT05038254Not applicable
- Tumor Antigen-sensitized DC Vaccine As an Adjuvant Therapy for Esophagus CancerCompletedNCT05023928Phase 1
- Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR AlterationsStatus unknownNCT05019794Phase 2
- TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.Status unknownNCT05013697Phase 2
- Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell CarcinomaCompletedNCT05007613Phase 2
- PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell CarcinomaStatus unknownNCT05007145Phase 2
- The Registry Study of Genetic Alterations of Esophageal Cancer in TaiwanActive, not recruitingNCT04996095
- Endoscopic Resection of Early Esophageal Tumors in the Context of Cirrhosis or Portal HypertensionCompletedNCT04994548
- Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWithdrawnNCT04985357
- Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric CancerCompletedNCT04984733Phase 2
- Anlotinib Combined With PD-1 Inhibitors for Advanced/Metastatic Esophageal CancerStatus unknownNCT04984096
- Tissue Oxygen Saturation for EsophagectomyCompletedNCT04973046
- Anlotinib for Esophageal Cancer (AFEC)Status unknownNCT04966611
- Endoscopic Assisted Calcium Electroporation in Esophageal CancerCompletedNCT04958044Phase 1
- NIF-Guided RAMIE Using ICG Versus OTE Feasibility RCTTerminatedNCT04938973Not applicable
- A One-arm, Prospective Study Comparing the Effects of Different Body Composition on the Survival of Patients Undergoing Radical Concurrent Chemoradiotherapy for Esophageal CancerStatus unknownNCT04936750
- A Study of Participants With Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part of an Early Access to Medicines Scheme (EAMS) Program in the United KingdomCompletedNCT04936399
- Real-world Data (RWD) of Ramucirumab Plus PaclitaxelStatus unknownNCT04915807
- A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1SuspendedNCT04908111Phase 1/2
- Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid TumorsCompletedNCT04902872Phase 1/2
- TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction AdenocarcinomaActive, not recruitingNCT04891900Not applicable
- Diagnostic Performance Indicators in Upper GI Endoscopy:PROSPERO StudyStatus unknownNCT04843397
- Evaluation of the Autonomic Nervous System in Patients Undergoing Esophagectomy for CancerWithdrawnNCT04835987
- DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)CompletedNCT04825834
- A Real-World Study of Immune Checkpoint Inhibitors and Chemotherapy for Advanced Esophageal CancerCompletedNCT04822103
- Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal CancerCompletedNCT04821765Phase 2
- Outcomes of Endoscopically Resected High-risk Mucosal and Low- and High-risk Submucosal Adenocarcinoma Arising in Barrett's EsophagusStatus unknownNCT04818476
- Pembrolizumab Plus Neoadjuvant Chemotherapy for Locally Advanced EGJ AdenocarcinomaStatus unknownNCT04813523Phase 2
- Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing TumorsActive, not recruitingNCT04802876Phase 2
- Predicting Disease Progression and/or Recurrence in CancerCompletedNCT04776837
- Chemoradiotherapy Plus Immunotherapy Followed by Surgery for Esophageal CancerActive, not recruitingNCT04776590Phase 2
- Incidence, Risk Factors and Consequences of Acute Kidney Injury in Patients Undergoing Esophageal Cancer SurgeryCompletedNCT04773080
- A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced MalignanciesCompletedNCT04772989Phase 1
- Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)Active, not recruitingNCT04764227Phase 2
- A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric CancerActive, not recruitingNCT04757363Phase 2
- A Study of KF-0210 in Advanced Solid Tumors PatientsCompletedNCT04713891Phase 1
- M1231 in Participants With Solid TumorsCompletedNCT04695847Phase 1
- Genomic Study of Relapse Esophageal Cancer After RadiotherapyStatus unknownNCT04694391
- COVID - 19 and Advanced Gastro-intestinal Cancer TreatmentCompletedNCT04686747
- Expanded Access Use of DKN-01 for the Treatment of Advanced Solid TumorsNo longer availableNCT04681248
- Prehabilitation on Fitness, Surgical Outcomes and Mitochondria Functionality in Patients With Esophageal CancerStatus unknownNCT04673968Not applicable
- Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerCompletedNCT04670445Not applicable
- Urokinase-type Plasminogen Activator Receptor and Gastroesophageal CancerCompletedNCT04669951Not applicable
- A Study of SGN-STNV in Advanced Solid TumorsTerminatedNCT04665921Phase 1
- Early Detection of Barrett's Esophagus in Participants With Reflux Symptoms in Primary CareCompletedNCT04656392Not applicable
- GASC1 Inhibitor Caffeic Acid for Squamous Esophageal Cell Cancer (ESCC)Status unknownNCT04648917Phase 3
- Nitrates and IL-8 in Barrett's EsophagusTerminatedNCT04642690
- Prevalence of Sub-epithelial Lesions Among Patients Undergoing EGDs in EgyptStatus unknownNCT04622098
- The Value of Lymph Node Dissection of Indocyanine Green-guided Near-infrared Fluorescent Imaging in EsophagectomyStatus unknownNCT04615806Not applicable
- Esophageal cAncer Screening TrialCompletedNCT04609813
- Yoga Program for Improving the Quality of Life in Couples Coping With CancerActive, not recruitingNCT04607590Not applicable
- A Study of SI-B001, an EGFR/HER3 Bispecific Antibody, in Locally Advanced or Metastatic Epithelial TumorsActive, not recruitingNCT04603287Phase 1
- NT-I7 in Combination With Nivolumab in Advanced Gastric, Gastro-Esophageal Junction or Esophageal AdenocarcinomaTerminatedNCT04594811Phase 1
- Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell InjectionActive, not recruitingNCT04581473Phase 1/2
- Prehabilitation in Esophageal Cancer CareStatus unknownNCT04581005Not applicable
- Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck CancerActive, not recruitingNCT04566367Not applicable
- Blood-borne Assessment of Stromal Activation in Esophageal Adenocarcinoma to Guide Tocilizumab TherapyActive, not recruitingNCT04554771Phase 2
- Gravity Assisted Technique for Esophageal Endoscopic Submucosal Dissection (ESD)CompletedNCT04547881
- Effects of Preoperative Enteral Immunonutrition for Esophageal Cancer Patients Given Neoadjuvant ChemoradiotherapyActive, not recruitingNCT04513418Phase 3
- A Clinical Study Of Camrelizumab With Or Without Radiotherapy In The Treatment Of Esophageal CancerStatus unknownNCT04512417Phase 2
- 99m Tc-3PRGD2 SPECT/CT Imaging in the Diagnosis of Lymph Node Metastasis of Esophageal CarcinomaStatus unknownNCT04504565Not applicable
- PD-1 Inhibitor INCMGA00012 as Consolidation Therapy After Definitive Concurrent ChemoradiotherapyActive, not recruitingNCT04494009Phase 2
- Response Prediction to Neoadjuvant Chemoradiation in Esophageal Cancer Using Artificial Intelligence & Machine LearningStatus unknownNCT04489368
- Non-curative ESDs: Assessing the Rates and Risk Factors for Residual NeoplasiaStatus unknownNCT04484311
- CCRT With Itraconazole in Locally Advanced Squamous Esophageal CancerStatus unknownNCT04481100Phase 2
- TC Plus PD-1 Inhibitors Combined With Anlotinib for Advanced Advanced Esophageal CancerStatus unknownNCT04471480Not applicable
- Health and Employment After Gastro Intestinal Surgery - HEAGIS2Status unknownNCT04466631
- Health and Employment After Gastro Intestinal Surgery - HEAGIS1CompletedNCT04466592Not applicable
- Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR CancersWithdrawnNCT04464967Phase 1/2
- A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma.Status unknownNCT04460066Phase 1/2
- Study of PF-07265807 in Participants With Metastatic Solid Tumors.TerminatedNCT04458259Phase 1
- Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS StudyCompletedNCT04449679Not applicable
- A Study of QL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer.Status unknownNCT04435652Phase 2/3
- Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SCompletedNCT04430842Phase 1
- Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal CancerStatus unknownNCT04426955Phase 3
- A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic EngineeringCompletedNCT04426669Phase 1/2
- A Prospective Clinical Study of Transthoracic Single-hole Assisted Laparoscopic Radical Gastrectomy for Siewert Ⅱ AEGStatus unknownNCT04423354Not applicable
- Clinical Control Study of Immunotherapy and Concurrent Chemoradiotherapy in Patients With Esophageal Cancer RecurrenceStatus unknownNCT04404491Phase 3
- Sentinel Lymph Node Mapping in Esophageal Cancer Using ICG Dye and NIR ImagingActive, not recruitingNCT04400292Not applicable
- Camrelizumab Combined With CRT for Treatment of Patients With Local Recurrence of Esophageal CancerStatus unknownNCT04390945Phase 2
- Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)Active, not recruitingNCT04379596Phase 2
- Assessment of Response to nCRT for GEJ Cancer Using a Fully Integrated PET/MRICompletedNCT04359732Not applicable
- National Cancer Institute "Cancer Moonshot Biobank"Active, not recruitingNCT04314401
- Radiogenomics in Aerodigestive Tract CancersCompletedNCT04314349
- Feasibility and Safety of Using Nasal High Flow Oxygen Postoperatively to Reduce Respiratory ComplicationsWithdrawnNCT04272268
- A Biomarker-driven Therapeutic Strategy for Esophageal Cancer Chemoradiotherapy in Patients With Resectable Adenocarcinoma of the ESophagus and Esophagogastric JunctionStatus unknownNCT04269083Not applicable
- Onco-primary Care Networking to Support TEAM-based CareActive, not recruitingNCT04258813Not applicable
- Cryotherapy for Locally Advanced Esophageal CancerActive, not recruitingNCT04248582Phase 1
- Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients.Active, not recruitingNCT04229459Phase 2
- A Comparison Between Ivor-Lewis and McKeown Minimally Invasive EsophagectomyCompletedNCT04217239Not applicable
- A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal CancerCompletedNCT04207918Phase 2
- The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal CancerCompletedNCT04196075Phase 3
- Retrospective Study of Ramucirumab and Paclitaxel in Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT04192734
- Perioperative Nutritional Support in Esophageal Cancer PatientsStatus unknownNCT04190121Not applicable